NCT04939051 2026-03-18
Obeticholic Acid for Prevention in Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
17 trialsNCT06732388 2026-03-18
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
NCT06803927 2026-03-18
DETECT-ME
Cyted Health Inc
Recruiting
NCT00587314 2026-03-11
ablation IN BE
Mayo Clinic
Enrolling by invitation
NCT07102329 2026-03-11
ESCAPE
IRCCS San Raffaele
Completed
NCT07455422 2026-03-06
Endeavor-2
University Hospital, Antwerp
Phase NA Not yet recruiting
NCT03554356 2026-02-27
NO FEAR-BE
University of North Carolina, Chapel Hill
Phase NA Active not recruiting
NCT07126535 2026-02-25
Impact of RFA on Esophageal Distensibility and Mucosal Impedance
Mayo Clinic
Recruiting
NCT06523374 2026-02-24
Endeavor-1
University Hospital, Antwerp
Phase NA Recruiting
NCT06346054 2026-02-17
MAGEC
KU Leuven
Phase NA Recruiting
NCT05468008 2026-02-02
ESD
AdventHealth
Recruiting
NCT03961945 2026-01-26
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Mayo Clinic
Phase NA Recruiting
NCT07206589 2026-01-23
Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
Mayo Clinic
Phase NA Not yet recruiting
NCT07335445 2026-01-16
Enhancing Screening Practices for BE
Rutgers, The State University of New Jersey
Phase NA Not yet recruiting
NCT07331857 2026-01-12
Digma System First in Human (FIH) Study
Digma Medical Ltd.
Phase NA Not yet recruiting
NCT07212491 2025-12-31
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Mayo Clinic
Enrolling by invitation
NCT01618643 2025-12-24
Aceto-whitening in the Assessment of Gastrointestinal Neoplasia
Portsmouth Hospitals NHS Trust
Completed